[Pharmacogenetic research in clinical psychiatry].
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001711:Biotransformation; D001714:Bipolar Disorder / Q000188:drug therapy; D002746:Chlorpromazine / Q000097:blood; D002802:Cholinesterases / Q000097:blood; D004342:Drug Hypersensitivity / Q000150:complications; D004790:Enzyme Induction; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications; D006801:Humans; D007538:Isoniazid / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D008862:Microsomes, Liver / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010597:Pharmacogenetics; D010672:Phenytoin / Q000009:adverse effects; D011110:Polymorphism, Genetic; D011164:Porphyrias / Q000150:complications; D011619:Psychotropic Drugs / Q000009:adverse effects
D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D011619:Psychotropic Drugs; D010672:Phenytoin; D002802:Cholinesterases; D002746:Chlorpromazine; D007538:Isoniazid
O famarkogeneticheskikh issledovaniiakh v klinicheskoĭ psikhiatrii